Leonie Voorwerk, MD, The Netherlands Cancer Institute, Amsterdam, The Netherlands, discusses the GELATO trial (NCT03147040), a single-arm, multicenter, non-randomized Phase II trial testing the efficacy of carboplatin and atezolizumab in metastatic lobular breast cancer (BC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).